In the News
NCCN
March 31-April 2, 2022
Join us at the National Comprehensive Cancer Network® 2022 Annual Conference virtual event.
ONS
April 27-May 1, 2022
Mark your calendar and visit us at the 47th Annual Oncology Nursing Society Congress in Anahein, CA.
sPCMA
February 28-March 3, 2022
Join us at the 2022 Specialty Pharmaceutical Care Management Business Forum in Orlando, FL.
ACCC
March 2-4, 2022
Join us at the ACCC 48th Annual Meeting & Cancer Center Business Summit in Washington, D.C.
COA
March 17-18, 2022
Visit us in booth #111 at the Community Oncology Alliance Annual Meeting in Kissimmee, FL.
HOPA
March 30-April 2, 2022
Visit us in booth #712 at the 2022 Hematology/Oncology Pharmacy Association Annual Conference in Boston, MA.
September 21, 2021
June 21, 2021
April 19, 2021
March, 2021
Downloadable Resources
At the forefront of health care innovation
Fresenius Kabi develops reliable, high-quality biosimilars for autoimmune diseases and oncology. Learn how we as a global health care company are at the forefront of health care innovation and patient care.
Providing Affordable Medicines
Fresenius Kabi: Caring for Life
What biosimilars means to me
Fresenius Kabi is a member of the Biosimilars Council
The Biosimilars Council works to ensure a positive regulatory, reimbursement, political and policy environment for biosimilar products. The council educates the public and patients about the safety and effectiveness of biosimilars, focusing on access, the regulatory environment, reimbursement and legal affairs.
Biosimilars Council Resources
(Please note: Fresenius Kabi is not responsible for the content of third-party websites.)
Looking for more information?
If you would like to know more about Fresenius Kabi and our unique approach to biosimilars, please get in touch.
Contact Us
Fresenius Kabi AG © June 2021 1702-BIOS-08-05/21